Atlas Trials

A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease

Clinical trial NCT01839526 · TERMINATED

Trial details

NCT number
NCT01839526
Sponsor
Genzyme, a Sanofi Company
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Fabry Disease
Start date
2013-05-01
Primary completion
2016-09-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.